1 Mid-Cap Stock to Keep an Eye On and 2 to Approach with CautionMany investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities.
However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
3 Small-Cap Stocks in Hot WaterSmall-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
3 Small-Cap Stocks in the DoghouseSmall-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings.
However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
3 Unprofitable Stocks with Questionable FundamentalsUnprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
3 Profitable Stocks Skating on Thin IceWhile profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
1 Volatile Stock That Stand Out and 2 to Brush OffVolatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
3 Stocks Under $50 That Concern UsStocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges.
However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.
1 Volatile Stock to Consider Right Now and 2 to QuestionMarket swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions.
While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
1 Stock Under $50 with Promising Prospects and 2 to Turn DownStocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks.
But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
3 of Wall Street’s Favorite Stocks with Questionable FundamentalsWall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
1 Volatile Stock with Impressive Fundamentals and 2 to Turn DownVolatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
1 Cash-Producing Stock with Exciting Potential and 2 to Think Twice AboutA company that generates cash isn’t automatically a winner.
Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand.
3 Value Stocks in Hot WaterValue stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
3 Volatile Stocks Skating on Thin IceA highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south.
While some investors embrace risk, mistakes can be costly for those who aren’t prepared.
3 Mid-Cap Stocks with Mounting ChallengesMid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets.
But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
3 of Wall Street’s Favorite Stocks Walking a Fine LineThe stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
3 Dawdling Stocks in the DoghouseA stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance.
Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.
1 Mid-Cap Stock That Stand Out and 2 to Think Twice AboutMid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
3 Value Stocks Facing HeadwindsValue investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices.
But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
3 Mid-Cap Stocks Facing HeadwindsMid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations.
However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
2 Profitable Stocks Worth Your Attention and 1 to Keep Off Your RadarNot all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
1 Safe-and-Steady Stock to Own for Decades and 2 to AvoidStability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
1 Unprofitable Stock with Competitive Advantages and 2 to QuestionUnprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around.
Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.
1 Industrials Stock to Consider Right Now and 2 to Approach with CautionIndustrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the market seems convinced that demand will slow.
Due to this bearish outlook, the industry has tumbled by 11.2% over the past six months. This drawdown was worse than the S&P 500’s 5.6% loss.
1 Value Stock Worth Investigating and 2 to Brush OffValue stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
1 Industrials Stock with Exciting Potential and 2 to Brush OffIndustrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the market seems convinced that demand will slow.
Due to this bearish outlook, the industry has tumbled by 11.2% over the past six months. This drop was worse than the S&P 500’s 5.6% loss.
3 Industrials Stocks Walking a Fine LineWhether you see them or not, industrials businesses play a crucial part in our daily activities. Still, their generally high capital requirements expose them to the ups and downs of economic cycles, and the market seems to be baking in a prolonged downturn
as the industry has shed 11.2% over the past six months. This drop was worse than the S&P 500’s 5.6% decline.
1 Small-Cap Stock with Solid Fundamentals and 2 to Steer Clear OfMany small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
3 Dawdling Stocks That Concern UsStability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
3 Small-Cap Stocks Facing HeadwindsInvestors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street.
Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
1 Cash-Heavy Stock with Impressive Fundamentals and 2 to IgnoreCompanies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments.
Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with CautionA surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth.
Some of these companies also face challenges like stagnating revenue, declining market share, or limited scalability.
2 Healthcare Stocks on Our Watchlist and 1 to Be Wary OfHealthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns -
over the past six months, healthcare stocks have collectively shed 10.9%. This performance was worse than the S&P 500’s 5.6% decline.
Corning (NYSE:GLW) Reports Sales Below Analyst Estimates In Q1 EarningsGlass and electronic component manufacturer Corning (
NYSE:GLW) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 16% year on year to $3.45 billion. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $3.85 billion at the midpoint, or 5% above analysts’ estimates. Its non-GAAP profit of $0.54 per share was 5.4% above analysts’ consensus estimates.
Insperity (NYSE:NSP) Reports Q1 In Line With Expectations But Stock Drops 13.4%HR outsourcing provider Insperity (
NYSE:NSP) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.4% year on year to $1.86 billion. Its non-GAAP profit of $1.57 per share was 22.4% below analysts’ consensus estimates.
Pfizer (NYSE:PFE) Misses Q1 Revenue EstimatesGlobal pharmaceutical company Pfizer (
NYSE:PFE) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 7.8% year on year to $13.72 billion. The company’s full-year revenue guidance of $62.5 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.92 per share was 35.2% above analysts’ consensus estimates.
Altria (NYSE:MO) Surprises With Strong Q1Tobacco company Altria (
NYSE:MO) announced better-than-expected revenue in Q1 CY2025, with sales up 11.5% year on year to $5.26 billion. Its non-GAAP profit of $1.23 per share was 3.5% above analysts’ consensus estimates.
PACCAR (NASDAQ:PCAR) Misses Q1 Sales Targets, Stock DropsTrucking company PACCAR (
NASDAQ:PCAR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 16% year on year to $6.91 billion. Its non-GAAP profit of $1.46 per share was 7.5% below analysts’ consensus estimates.
Commvault Systems (NASDAQ:CVLT) Reports Bullish Q1, Stock SoarsData backup provider Commvault (
NASDAQ:CVLT) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 23.2% year on year to $275 million. Guidance for next quarter’s revenue was better than expected at $268 million at the midpoint, 1.8% above analysts’ estimates. Its non-GAAP profit of $1.03 per share was 11% above analysts’ consensus estimates.
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q1, Full-Year Outlook Slightly Exceeds ExpectationsBiopharma manufacturing company Repligen Corporation (
NASDAQ:RGEN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.4% year on year to $169.2 million. The company’s full-year revenue guidance of $707.5 million at the midpoint came in 1% above analysts’ estimates. Its non-GAAP profit of $0.39 per share was 11.4% above analysts’ consensus estimates.
Hillman (NASDAQ:HLMN) Misses Q1 Revenue EstimatesHardware products and merchandising solutions provider Hillman (
NASDAQ:HLMN) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 2.6% year on year to $359.3 million. On the other hand, the company’s full-year revenue guidance of $1.54 billion at the midpoint came in 0.5% above analysts’ estimates. Its non-GAAP profit of $0.10 per share was in line with analysts’ consensus estimates.
NeoGenomics (NASDAQ:NEO) Misses Q1 Sales Targets, Stock DropsOncology (cancer) diagnostics company NeoGenomics (
NASDAQ:NEO) fell short of the market’s revenue expectations in Q1 CY2025, but sales rose 7.5% year on year to $168 million. On the other hand, the company’s full-year revenue guidance of $753 million at the midpoint came in 2% above analysts’ estimates. Its non-GAAP loss of $0 per share was in line with analysts’ consensus estimates.
Kraft Heinz (NASDAQ:KHC) Reports Q1 In Line With ExpectationsPackaged foods company Kraft Heinz (
NASDAQ:KHC) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 6.4% year on year to $6.00 billion. Its non-GAAP profit of $0.62 per share was 2.7% above analysts’ consensus estimates.
Cushman & Wakefield’s (NYSE:CWK) Q1 Sales Beat Estimates, Stock SoarsReal estate services firm Cushman & Wakefield (
NYSE:CWK) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 4.6% year on year to $2.28 billion. Its non-GAAP profit of $0.09 per share was significantly above analysts’ consensus estimates.
General Motors (NYSE:GM) Surprises With Q1 SalesAutomotive manufacturer General Motors (
NYSE:GM) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 2.3% year on year to $44.02 billion. Its non-GAAP profit of $2.78 per share was 4.3% above analysts’ consensus estimates.
LGI Homes (NASDAQ:LGIH) Reports Sales Below Analyst Estimates In Q1 EarningsAffordable single-family home construction company LGI Homes (
NASDAQ:LGIH) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 10.1% year on year to $351.4 million. Its GAAP profit of $0.17 per share was 73.1% below analysts’ consensus estimates.
CECO Environmental (NASDAQ:CECO) Delivers Impressive Q1, Full-Year Sales Guidance is OptimisticEnvironmental solutions provider CECO Environmental (
NASDAQ:CECO) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 39.9% year on year to $176.7 million. The company’s full-year revenue guidance of $725 million at the midpoint came in 3.5% above analysts’ estimates. Its non-GAAP profit of $0.10 per share was 17.6% above analysts’ consensus estimates.
Astec’s (NASDAQ:ASTE) Q1: Beats On Revenue, Stock SoarsConstruction equipment company Astec (
NASDAQ:ASTE) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 6.5% year on year to $329.4 million. Its non-GAAP profit of $0.88 per share was 91.3% above analysts’ consensus estimates.
Option Care Health (NASDAQ:OPCH) Delivers Impressive Q1, Full-Year Outlook Slightly Exceeds ExpectationsAlternate site health provider Option Care Health (
NASDAQ:OPCH) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 16.3% year on year to $1.33 billion. The company’s full-year revenue guidance of $5.5 billion at the midpoint came in 1.3% above analysts’ estimates. Its non-GAAP profit of $0.40 per share was 19% above analysts’ consensus estimates.
Incyte (NASDAQ:INCY) Delivers Strong Q1 NumbersBiopharmaceutical company Incyte Corporation (
NASDAQ:INCY) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 19.5% year on year to $1.05 billion. Its non-GAAP profit of $1.16 per share was 10.6% above analysts’ consensus estimates.
Xylem’s (NYSE:XYL) Q1 Sales Beat EstimatesWater technology company Xylem (
NYSE:XYL) announced better-than-expected revenue in Q1 CY2025, with sales up 1.8% year on year to $2.07 billion. The company expects the full year’s revenue to be around $8.75 billion, close to analysts’ estimates. Its non-GAAP profit of $1.03 per share was 8% above analysts’ consensus estimates.
A. O. Smith’s (NYSE:AOS) Q1: Beats On RevenueWater heating and treatment solutions company A.O. Smith (
NYSE:AOS) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.5% year on year to $963.9 million. The company’s full-year revenue guidance of $3.85 billion at the midpoint came in 0.5% above analysts’ estimates. Its GAAP profit of $0.95 per share was 5.4% above analysts’ consensus estimates.
Coca-Cola’s (NYSE:KO) Q1 Earnings Results: Revenue In Line With ExpectationsBeverage company Coca-Cola (
NYSE:KO) met Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $11.13 billion. Its non-GAAP profit of $0.73 per share was 1.9% above analysts’ consensus estimates.
Sherwin-Williams (NYSE:SHW) Misses Q1 Sales TargetsPaint and coating manufacturer Sherwin-Williams (
NYSE:SHW) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1.1% year on year to $5.31 billion. Its non-GAAP profit of $2.25 per share was 4.1% above analysts’ consensus estimates.
Tenet Healthcare (NYSE:THC) Surprises With Q1 SalesHospital operator Tenet Healthcare (
NYSE:THC) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 2.7% year on year to $5.22 billion. The company expects the full year’s revenue to be around $20.8 billion, close to analysts’ estimates. Its non-GAAP profit of $4.36 per share was 39.2% above analysts’ consensus estimates.
Labcorp (NYSE:LH) Reports Sales Below Analyst Estimates In Q1 EarningsHealthcare diagnostics company Labcorp Holdings (
NYSE:LH) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 5.3% year on year to $3.35 billion. Its non-GAAP profit of $3.84 per share was 2.8% above analysts’ consensus estimates.
Brinker International (NYSE:EAT) Posts Better-Than-Expected Sales In Q1 But Stock Drops 12.8%Casual restaurant chain Brinker International (
NYSE:EAT) announced better-than-expected revenue in Q1 CY2025, with sales up 27.2% year on year to $1.43 billion. The company’s full-year revenue guidance of $5.34 billion at the midpoint came in 1.8% above analysts’ estimates. Its non-GAAP profit of $2.66 per share was 3.6% above analysts’ consensus estimates.
Zebra (NASDAQ:ZBRA) Exceeds Q1 Expectations, Stock SoarsEnterprise data capture company Zebra Technologies (
NASDAQ:ZBRA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.3% year on year to $1.31 billion. The company expects next quarter’s revenue to be around $1.28 billion, close to analysts’ estimates. Its non-GAAP profit of $4.02 per share was 11.1% above analysts’ consensus estimates.
Regeneron (NASDAQ:REGN) Misses Q1 Sales TargetsBiotech company Regeneron (
NASDAQ:REGN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.7% year on year to $3.03 billion. Its non-GAAP profit of $8.22 per share was 3% below analysts’ consensus estimates.
Royal Caribbean (NYSE:RCL) Posts Q1 Sales In Line With EstimatesCruise vacation company Royal Caribbean (
NYSE:RCL) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.3% year on year to $4.00 billion. Its non-GAAP profit of $2.71 per share was 7% above analysts’ consensus estimates.
Hilton (NYSE:HLT) Reports Sales Below Analyst Estimates In Q1 EarningsHotel company Hilton (
NYSE:HLT) fell short of the market’s revenue expectations in Q1 CY2025 as sales rose 4.7% year on year to $2.70 billion. Its non-GAAP profit of $1.72 per share was 7% above analysts’ consensus estimates.
Armstrong World (NYSE:AWI) Posts Better-Than-Expected Sales In Q1Ceiling and wall solutions company Armstrong World Industries (
NYSE:AWI) announced better-than-expected revenue in Q1 CY2025, with sales up 17.3% year on year to $382.7 million. The company expects the full year’s revenue to be around $1.59 billion, close to analysts’ estimates. Its non-GAAP profit of $1.66 per share was 8.7% above analysts’ consensus estimates.
United Parcel Service (NYSE:UPS) Exceeds Q1 ExpectationsParcel delivery company UPS (
NYSE:UPS) reported Q1 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $21.5 billion. Its non-GAAP profit of $1.49 per share was 7.9% above analysts’ consensus estimates.
ArcBest (NASDAQ:ARCB) Reports Sales Below Analyst Estimates In Q1 EarningsFreight Delivery Company ArcBest (
NASDAQ:ARCB) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.7% year on year to $967.1 million. Its non-GAAP profit of $0.51 per share was in line with analysts’ consensus estimates.
Honeywell’s (NASDAQ:HON) Q1 Sales Beat EstimatesIndustrial conglomerate Honeywell (
NASDAQ:HON) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 7.9% year on year to $9.82 billion. On the other hand, the company’s full-year revenue guidance of $40.05 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $2.51 per share was 13.6% above analysts’ consensus estimates.
Winners And Losers Of Q4: Evolent Health (NYSE:EVH) Vs The Rest Of The Healthcare Technology for Providers StocksThe end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Evolent Health (
NYSE:EVH) and the rest of the healthcare technology for providers stocks fared in Q4.
2 Reasons to Watch IONQ and 1 to Stay CautiousIonQ has been on fire lately. In the past six months alone, the company’s stock price has rocketed 72.6%, reaching $28.90 per share. This performance may have investors wondering how to approach the situation.
3 Reasons J is Risky and 1 Stock to Buy InsteadOver the last six months, Jacobs Solutions shares have sunk to $123.15, producing a disappointing 13.8% loss - worse than the S&P 500’s 5% drop. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Lincoln Educational (LINC): Buy, Sell, or Hold Post Q4 Earnings?Lincoln Educational currently trades at $17.36 and has been a dream stock for shareholders. It’s returned 594% since April 2020, blowing past the S&P 500’s 88.4% gain. The company has also beaten the index over the past six months as its stock price is up 32.1% thanks to its solid quarterly results.
Q4 Earnings Roundup: Zoom (NASDAQ:ZM) And The Rest Of The Video Conferencing SegmentAs the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the video conferencing industry, including Zoom (
NASDAQ:ZM) and its peers.
3 Reasons LW is Risky and 1 Stock to Buy InsteadLamb Weston’s stock price has taken a beating over the past six months, shedding 33.1% of its value and falling to $51.75 per share. This may have investors wondering how to approach the situation.
Accenture (ACN): Buy, Sell, or Hold Post Q4 Earnings?Over the past six months, Accenture’s shares (currently trading at $294.75) have posted a disappointing 18.8% loss while the S&P 500 was down 5%. This may have investors wondering how to approach the situation.
eHealth (EHTH): Buy, Sell, or Hold Post Q4 Earnings?Even during a down period for the markets, eHealth has gone against the grain, climbing to $6.02. Its shares have yielded a 20.4% return over the last six months, beating the S&P 500 by 25.5%. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Badger Meter (BMI): Buy, Sell, or Hold Post Q1 Earnings?Badger Meter currently trades at $217.07 and has been a dream stock for shareholders. It’s returned 244% since April 2020, nearly tripling the S&P 500’s 88.4% gain. The company has also beaten the index over the past six months as its stock price is up 6.4% thanks to its solid quarterly results.
Video Gaming Stocks Q4 Highlights: Roblox (NYSE:RBLX)Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Roblox (
NYSE:RBLX) and its peers.
